1. Executive Summary
2. Research Methodology
3. Hair Loss
3.1 Overview
3.2 Types of Hair Loss
3.2.1 Androgenetic Alopecia
3.2.2 Telogen Effluvium
3.2.3 Alopecia Areata
3.2.4 Others
3.3 Causes
3.4 Treatment
3.4.1 Non-Surgical Options
3.4.2 Surgical Procedures
3.4.2.1 Hair Transplant
3.4.2.2 Scalp Treatment
4. Hair Transplant
4.1 Overview
4.2 Methodology
4.2.1 Follicular Unit Extraction (FUE)
4.2.2 Follicular Unit Transplantation (FUT)
4.3 Therapy
4.3.1 Platelet Rich Plasma (PRP) Therapy
4.3.2 Stem Cell Therapy
4.3.3 Ravage 670 Laser
5. Market Analysis
5.1 Market Sizing (Actual & Forecasted)
5.2 Market Share Analysis
5.2.1 Market Share by Procedure
5.2.2 Market Share by Methodology
5.2.3 Market Share by Therapy
5.2.4 Market Share by Product
5.2.5 Market Share by Site of Transplant
5.2.6 Market Share by Gender
5.2.7 Market Share by Service Provider
5.2.8 Market Share by Region
5.3 Pricing Analysis
6. Market Segmentation
6.1 By Methodology
6.1.1 Follicular Unit Extraction (FUE)
6.1.1.1 Market Sizing (Actual & Forecasted)
6.1.2 Follicular Unit Transplantation (FUT)
6.1.2.1 Market Sizing (Actual & Forecasted)
6.2 By Therapy
6.2.1 Platelet Rich Plasma
6.2.1.2 Market Sizing (Actual & Forecasted)
6.2.2 Stem Cell Therapy
6.2.2.2 Market Sizing (Actual & Forecasted)
7. Regional Analysis
7.1 North America
7.1.1 Market Sizing (Actual & Forecasted)
7.1.2 The US
7.1.2.1 Market Sizing (Actual & Forecasted)
7.1.2.2 Market Share by Product
7.2 Europe
7.2.1 Market Sizing (Actual & Forecasted)
7.2.2 Turkey
7.2.2.1 Market Sizing (Actual & Forecasted)
7.3 Asia Pacific
7.3.1 Market Sizing (Actual & Forecasted)
7.3.2 India
7.3.2.1 Market Sizing (Actual & Forecasted)
8. Market Dynamics
8.1 Industry Trends & Developments
8.1.1 Technological Innovation
8.1.2 Neograft FUE Hair Transplant
8.1.3 3D Printed Cranial Hair & Scalp Prosthesis
8.1.4 Higher Demand for Less Invasive Restoration Procedures
8.2 Growth Drivers
8.2.1 Prevalence of People with Hair Loss
8.2.2 Rise in Disposable Income
8.2.3 Ageing Population
8.2.4 Changing Lifestyle
8.3 Challenges
8.3.1 Expensive Treatment
8.3.2 Government Regulations
8.3.3 Adverse Side Effects of Drugs
8.3.4 Ineffectiveness of Currently Available Options
9. Competitive Landscape
9.1 Market Share Analysis
9.2 Financial Analysis
10. Company Profiles
10.1 Restoration Robotics Inc.
10.2 Bernstein Medical (US)
10.3 Bosley Cole Instruments
10.4 Medicamat
10.5 Neograft Solutions (Venus Concept)